Home>Topics>Stocks>C.R. Bard

C.R. Bard

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. Headlines
  1. Why I'm Bullish On Facebook Long Term


    Tue, 24 Jun 2014

    By BCR BlackArbs : I am bullish on Facebook ( FB ) because I believe the firm's strategic vision is sound and recent moves have put

  2. New Morningstar Analyst Report for Endo International PLC

    Stock Reports

    Thu, 19 Jun 2014

    facing lawsuits related to patient injuries caused by its vaginal mesh products. The issue is not unique to Endo--competitors CR Bard , Boston Scientific, Johnson & Johnson, and others are facing litigation for similar products--but it could face a significant

  3. Ad Comm recommends approval for Bard catheter


    Fri, 13 Jun 2014

    unanimous vote , the FDA's Circulatory System Devices Advisory Panel unanimously recommends regulatory approval for C . R . Bard 's ( BCR ) Lutonix Drug Coated PTA Catheter (DCB). The device is currently under agency review for improving luminal

  4. Bard to buy back $500M in shares


    Wed, 11 Jun 2014

    The BOD of C . R . Bard ( BCR -2.2% ) authorizes the repurchase of $500M of the company's common stock. This is in addition to the ~$30M remaining under its prior authorization announced in January 2014. Post your comment!

  5. Baxter International - A Quality Dividend Stock Selling For Bargain Prices


    Mon, 9 Jun 2014

    dividend to 52 cents /share. The company's peer group includes Medtronic ( MDT ), Becton Dickinson ( BDX ) and C . R . Bard ( BCR ). Over the past decade this dividend growth stock has delivered an annualized total return of 11.30% to its

  6. New Morningstar Analyst Report for CR Bard Inc

    Stock Reports

    Tue, 22 Apr 2014

    substantial market share decline for Bard. C . R . Bard 's line of infection-control products ..... when capital spending is low. We rate C . R . Bard 's stewardship as Standard. Chairman ..... lower executive compensation rates than C . R . Bard . We also would like to see more disclosure

  7. CR Bard Sees Boost in First Quarter Thanks to Gore Royalties and Acquisitions


    Tue, 22 Apr 2014

    CR Bard reported first-quarter results that slightly exceeded our expectations, thanks to acquisitions made last year as well as royalty

  8. CR Bard Underlying Business Remains Solid in Fourth Quarter


    Fri, 31 Jan 2014

    CR Bard released solid fourth-quarter performance that generally matched our expectations, and we are leaving our fair value estimate

  9. Our Outlook for Health-Care Stocks


    Tue, 31 Dec 2013

    see China as a strategic priority and invested heavily to put down roots there. On the other hand, Edwards EW and C . R . Bard BCR have invested far less extensively in China and do not seem to view penetration of this market as a corporate priority

  10. CR Bard Reports Strong 3Q and We Plan to Raise our Fair Value Estimate


    Tue, 22 Oct 2013

    CR Bard posted strong third-quarter results that slightly exceeded our expectations. We plan to modestly raise our fair value estimate

« Prev1234Next »
Content Partners